Wird geladen...
Dual HER2 blockade: preclinical and clinical data
The estrogen receptor and human epidermal growth factor receptor (HER) signaling pathways are the dominant drivers of cell proliferation and survival in the majority of human breast cancers. Not surprisingly, targeting these pathways provides the most effective therapies in appropriately selected pa...
Gespeichert in:
| Veröffentlicht in: | Breast Cancer Res |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4429364/ https://ncbi.nlm.nih.gov/pubmed/25928889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-014-0419-5 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|